生物工艺容器市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按容器类型、按应用、最终用户、地区和竞争细分

预计生物工艺容器市场在预测期内将出现令人印象深刻的增长。这可以归因于生物製药行业对自动化和机器学习实施的需求不断增长，以及全球范围内为开发新产品而引入技术先进的产品。生物工艺容器是生物製药製造工艺的关键组成部分，为传统不銹钢设备提供了可靠且经济高效的替代方案。在过去的几年中，与生物工艺容器相关的重大发展和趋势已经出现。一次性生物工艺容器的采用是由其灵活性、可扩展性和成本效益推动的。智能传感器和物联网 (IoT) 正在改变生物製药行业，生物工艺容器也不例外。生物工艺容器现在采用智能传感器进行设计，可实时监测和控制温度、pH 值和溶解氧水平等关键工艺参数。这使得生物製药製造商能够优化其工艺、减少浪费并提高产品质量。与生物工艺容器相关的主要挑战之一是标准化。目前，生物工艺容器尚无行业标准，每个製造商可能有自己的设计、材料和製造工艺。缺乏标准化可能使生物製药製造商在比较和选择生物工艺容器时面临挑战，从而导致效率低下和成本增加。与传统不銹钢设备相比，生物工艺容器具有多种优势，包括减少资本支出、提高灵活性和提高效率。随着生物製药製造商寻求优化其生产工艺并降低成本，预计生物工艺容器市场在未来几年将继续增长。可扩展性是与生物工艺容器相关的另一个挑战。生物製药製造商可能需要快速扩大或缩小其生产流程，以满足不断变化的需求。生物工艺容器的设计必须能够适应生产中的这些变化，同时又不影响产品质量或效率。这可能具有挑战性，因为生物工艺容器可能需要针对特定​​应用进行定制，并且可能不易扩展。生物工艺容器通常用于生物製药行业的细胞培养。这些容器旨在支持细胞的生长和生产，并且可以轻鬆定制以满足不同细胞系的特定需求。生物工艺容器还用于基因治疗，涉及将遗传物质转移到患者的细胞中以治疗或预防疾病。这些容器用于培养和生产基因治疗中使用的病毒载体，并且可以轻鬆修改以满足不同载体系统的特定需求。

对生物製药产品的需求不断增加

过去几年，由于人口老龄化、慢性病发病率上升以及对更有效治疗方法的需求，对生物製药产品的需求一直在稳步增长。与传统製造方法相比，生物工艺容器具有多种优势，包括更大的灵活性、更低的污染风险和更低的成本，使其成为寻求提高产能的公司的有吸引力的选择。随着製造商寻求更灵活的解决方案，可以轻鬆适应不同的生产工艺，我们预计生物工艺容器设计将出现更多的定制化和模块化。这将有助于降低成本并提高效率，同时仍保证生物製药产品的质量和纯度。

越来越多地采用一次性技术

生物工艺容器是一次性技术的关键组成部分，该技术在生物製药行业迅速受到关注。与传统不銹钢设备相比，这些技术具有多种优势，包括较低的资本成本、减少的清洁和验证要求以及更快的周转时间。随着一次性技术的采用不断增加，对生物工艺容器的需求也随之增加。一次性技术已经彻底改变了生物製药製造，我们预计该领域将持续增长。这将包括开发新型生物工艺容器以及其他一次性组件，例如过滤器和泵。

对具有成本效益和高效的生产方法的需求不断增长

生物工艺容器的设计具有成本效益和高效性，使其成为寻求降低製造成本和提高产能的公司的有吸引力的选择。与传统的不銹钢设备相比，生物工艺容器需要更少的设置和清洁时间，从而缩短周转时间并提高生产率。此外，生物工艺容器可以定制以满足特定的客户要求，从而在製造过程中实现更大的灵活性和效率。 GE医疗集团于2019年推出了新型生物反应器系统。ReadyToProcess WAVE 25是一次性生物反应器系统，可用于细胞培养和发酵过程。该系统具有预组装的一次性生物工艺容器，可以轻鬆集成到现有的製造工艺中。生物工艺容器通常由耐生物製药产品的材料製成，旨在最大限度地降低污染风险。这有助于确保生物製药产品的质量和纯度，这对于法规遵从性和患者安全至关重要。

COVID-19 大流行的影响

COVID-19 大流行对生物製药行业产生了重大影响，世界各地的公司都在加大疫苗和其他生物製品的生产。生物工艺容器在这一努力中发挥了关键作用，使公司能够迅速扩大生产规模并满足对这些产品不断增长的需求。随着这一流行病继续影响世界各地的人口，对生物工艺容器的需求可能会保持强劲。

更加关注可持续性和环境友好性

可持续性和环境友好性对于生物製药製造商来说变得越来越重要。许多公司现在专注于减少碳足迹并最大限度地减少浪费。生物工艺容器在这一趋势中发挥着重要作用，因为它们专为一次性应用而设计，减少了清洁和灭菌过程的需求。此外，许多生物工艺容器製造商正在使用环保材料和製造工艺来减少对环境的影响。默克于 2020 年推出了 Mobius MyWay 产品组合，其中包括一系列一次性生物工艺容器、过滤产品和其他组件。 MyWay 产品组合旨在为不同的生物製药製造工艺提供定制解决方案。生物工艺容器设计为一次性使用，这意味着它们在使用后可以轻鬆处置。这消除了耗时的清洁和灭菌过程，从而可以提高整体製造效率。此外，生物工艺容器可以预先组装和预先消毒，这进一步减少了设置所需的时间和精力。

技术不断进步

生物工艺容器技术的进步也促进了市场的增长。例如，高性能薄膜和涂层的开发使生物工艺容器能够承受更极端的条件，例如高压和高温。此外，智能传感器和RFID技术的使用可以更好地控制和监控製造过程，提高产品质量和安全性。

在过去的三年里，已经推出了多种与生物工艺容器相关的产品，旨在提高生物製药製造的效率、可靠性和性能。这些产品的发布采用了新的薄膜技术、先进的传感器和独特的叶轮技术以及其他创新。随着生物製药行业的不断发展，我们预计将会看到更多旨在提高生物工艺容器的效率和可靠性的产品。总体而言，在预测期内，对生物製药的需求不断增长以及对更高效、更具成本效益的製造解决方案的需求预计将继续推动生物工艺容器市场的增长。

近期发展

• 2020 年，赛多利斯推出了 BIOSTAT STR 一次性生物反应器，专为大规模细胞培养过程而设计。该生物反应器具有独特的摇摆运动，模仿搅拌罐生物反应器的温和搅拌，确保一致的混合和氧气转移。该系统还包括一系列用于实时监测和控制生物过程的传感器。
• 2020 年，颇尔公司推出了 Allegro 一次性系统，专为生物製药製造应用而设计。该系统包括一系列一次性容器，包括袋子、管道和连接器，专为流体管理、过滤和生物反应器应用而设计。 Allegro 系统旨在降低污染风险并提高工艺灵活性和可扩展性。
• 2019 年，赛默飞世尔科技推出了 HyPerforma 一次性生物反应器，专为高密度细胞培养过程而设计。该生物反应器采用了新的薄膜技术，可以增强氧气传输、更好的混合併改善 pH 控制。该系统还配备先进的传感器，用于实时监测和控制生物过程。

可用的定制：

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

• 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场细分

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要行业合作伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量和验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球生物工艺容器市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按容器类型（2D 生物工艺容器、3D 生物工艺容器、其他容器和配件）
  • 按应用（上游工艺、下游工艺、工艺开发）
  • 按最终用户（生物製药公司、生命科学研发公司、其他）
  • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
  • 按公司划分 (2022)
• 市场地图
  • 按集装箱类型
  • 按应用
  • 由最终用户
  • 按地区

第 6 章：北美生物工艺容器市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按容器类型（2D、3D、其他容器和配件）
  • 按应用（上游工艺、下游工艺、工艺开发）
  • 按最终用户（生物製药公司、生命科学研发公司、其他）
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲生物工艺容器市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按容器类型（2D、3D、其他容器和配件）
  • 按应用（上游工艺、下游工艺、工艺开发）
  • 按最终用户（生物製药公司、生命科学研发公司、其他）
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第 8 章：亚太地区生物工艺容器市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按容器类型（2D、3D、其他容器和配件）
  • 按应用（上游工艺、下游工艺、工艺开发）
  • 按最终用户（生物製药公司、生命科学研发公司、其他）
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第 9 章：南美生物工艺容器市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按容器类型（2D、3D、其他容器和配件）
  • 按应用（上游工艺、下游工艺、工艺开发）
  • 按最终用户（生物製药公司、生命科学研发公司、其他）
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲生物工艺容器市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按容器类型（2D 生物工艺容器、3D 生物工艺容器、其他容器和配件）
  • 按应用（上游工艺、下游工艺、工艺开发）
  • 按最终用户（生物製药公司、生命科学研发公司、其他）
  • 按国家/地区
• MEA：国家分析
  • 南非生物工艺容器
  • 沙特阿拉伯生物工艺容器
  • 阿联酋生物工艺容器

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球生物工艺容器市场：SWOT 分析

第 14 章：波特的五力分析

• 行业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• 商业概览
• 产品供应
• 最近的发展
• 财务（据报导）
• 主要人员
• SWOT分析
  • Thermo Fisher Scientific Inc.
  • Cytiva Europe GmbH.
  • Saint-Gobain Group.
  • Lonza Group AG.
  • Avantor Funding Inc.
  • Merck KGaA.
  • Sartorius AG.
  • CellBios Healthcare and Lifesciences Pvt Ltd.
  • Cole-Parmer Instrument Co.
  • Biomass Ventures Pte Ltd.

第 16 章：战略建议

Bioprocess Containers market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising demand for the implementation of automation and machine learning in the biopharmaceutical industry, along with the introduction of technologically advanced products for the development of novel products across the globe. Bioprocess containers are a critical component of the biopharmaceutical manufacturing process, providing a reliable and cost-effective alternative to traditional stainless-steel equipment. Over the past few years, there have been significant developments and trends related to bioprocess containers. The adoption of single-use bioprocess containers has been driven by their flexibility, scalability, and cost-effectiveness. Smart sensors and the Internet of Things (IoT) are transforming the biopharmaceutical industry, and bioprocess containers are no exception. Bioprocess containers are now being designed with smart sensors that provide real-time monitoring and control of critical process parameters such as temperature, pH, and dissolved oxygen levels. This enables biopharmaceutical manufacturers to optimize their processes, reduce waste, and improve product quality. One of the main challenges related to bioprocess containers is standardization. Currently, there are no industry-wide standards for bioprocess containers, and each manufacturer may have their own design, material, and manufacturing process. This lack of standardization can make it challenging for biopharmaceutical manufacturers to compare and select bioprocess containers, which can lead to inefficiencies and added costs. Bioprocess containers offer several advantages over traditional stainless-steel equipment, including reduced capital expenditures, improved flexibility, and increased efficiency. The market for bioprocess containers is expected to continue to grow in the coming years as biopharmaceutical manufacturers seek to optimize their production processes and reduce costs. Scalability is another challenge related to bioprocess containers. Biopharmaceutical manufacturers may need to scale up or down their production processes quickly to meet changing demand. Bioprocess containers must be designed to accommodate these changes in production without compromising product quality or efficiency. This can be challenging, as bioprocess containers may need to be customized for specific applications and may not be easily scalable. Bioprocess containers are commonly used for cell culture in the biopharmaceutical industry. These containers are designed to support the growth and production of cells and can be easily customized to meet the specific needs of different cell lines. Bioprocess containers are also used in gene therapy, which involves the transfer of genetic material into a patient's cells to treat or prevent disease. These containers are used to culture and produce the viral vectors used in gene therapy and can be easily modified to meet the specific needs of different vector systems.

Increasing Demand for Biopharmaceutical Products

The demand for biopharmaceutical products has been increasing steadily over the past few years, driven by an aging population, rising incidence of chronic diseases, and the need for more effective treatments. Bioprocess containers offer several advantages over traditional manufacturing methods, including greater flexibility, reduced risk of contamination, and lower costs, making them an attractive option for companies looking to increase their production capacity. We can expect to see more customization and modularization in bioprocess container design as manufacturers look for more flexible solutions that can be easily adapted to different production processes. This will help to reduce costs and improve efficiency while still ensuring the quality and purity of biopharmaceutical products.

Growing Adoption of Single-use Technologies

Bioprocess containers are a key component of single-use technologies, which are rapidly gaining traction in the biopharmaceutical industry. These technologies offer several advantages over traditional stainless-steel equipment, including lower capital costs, reduced cleaning and validation requirements, and faster turnaround times. As the adoption of single-use technologies continues to increase, so too will the demand for bioprocess containers. Single-use technology has already revolutionized biopharmaceutical manufacturing, and we can expect to see continued growth in this area. This will include the development of new types of bioprocess containers, as well as other single-use components such as filters and pumps.

Growing demand for Cost-effective and efficient production methods

Bioprocess containers are designed to be cost-effective and efficient, making them an attractive option for companies looking to reduce manufacturing costs and increase production capacity. Compared to traditional stainless-steel equipment, bioprocess containers require less time for setup and cleaning, resulting in faster turnaround times and greater productivity. In addition, bioprocess containers can be customized to meet specific customer requirements, allowing for greater flexibility and efficiency in the manufacturing process. GE Healthcare launched a new bioreactor system in 2019. The ReadyToProcess WAVE 25 is a single-use bioreactor system that can be used for cell culture and fermentation processes. The system features a pre-assembled single-use bioprocess container and can be easily integrated into existing manufacturing processes. Bioprocess containers are typically made from materials that are resistant to biopharmaceutical products and are designed to minimize the risk of contamination. This can help ensure the quality and purity of biopharmaceutical products, which is critical for regulatory compliance and patient safety.

Effect of the COVID-19 Pandemic

The COVID-19 pandemic has had a significant impact on the biopharmaceutical industry, with companies around the world ramping up production of vaccines and other biologics. Bioprocess containers have played a critical role in this effort, enabling companies to rapidly scale up production and meet the growing demand for these products. As the pandemic continues to affect populations around the world, the demand for bioprocess containers is likely to remain strong.

Increased Focus on Sustainability and Environmental Friendliness

Sustainability and environmental friendliness are becoming increasingly important for biopharmaceutical manufacturers. Many companies are now focused on reducing their carbon footprint and minimizing waste. Bioprocess containers are playing a significant role in this trend, as they are designed for single-use applications, reducing the need for cleaning and sterilization processes. Moreover, many bioprocess container manufacturers are using environment-friendly materials and manufacturing processes to reduce their impact on the environment. Merck launched its Mobius MyWay portfolio in 2020, which includes a range of single-use bioprocess containers, filtration products, and other components. The MyWay portfolio is designed to provide customized solutions for different biopharmaceutical manufacturing processes. Bioprocess containers are designed for single use, which means they can be easily disposed of after use. This eliminates the need for time-consuming cleaning and sterilization processes, which can improve overall manufacturing efficiency. Additionally, bioprocess containers can be pre-assembled and pre-sterilized, which further reduces the time and effort required for setup.

Growing Technological Advancements

Advancements in bioprocess container technology have also contributed to the growth of the market. For example, the development of high-performance films and coatings has enabled bioprocess containers to withstand more extreme conditions, such as high pressures and temperatures. In addition, the use of smart sensors and RFID technology has enabled greater control and monitoring of the manufacturing process, improving product quality and safety.

The past three years have seen several product launches related to bioprocess containers that have aimed to improve the efficiency, reliability, and performance of biopharmaceutical manufacturing. These product launches have incorporated new film technology, advanced sensors, and unique impeller technology, among other innovations. As the biopharmaceutical industry continues to evolve, we can expect to see further product launches aimed at improving the efficiency and reliability of bioprocess containers. Overall, the increasing demand for biopharmaceuticals and the need for more efficient and cost-effective manufacturing solutions are expected to continue to drive the growth of the bioprocess container market during the forecast period.

Recent Development

• In 2020, Sartorius launched its BIOSTAT STR single-use bioreactor, designed for large-scale cell culture processes. The bioreactor features a unique rocking motion that mimics the gentle agitation of stirred-tank bioreactors, ensuring consistent mixing and oxygen transfer. The system also includes a range of sensors for real-time monitoring and control of the bioprocess.
• In 2020, Pall Corporation launched its Allegro single-use systems, designed for biopharmaceutical manufacturing applications. The system includes a range of single-use containers, including bags, tubing, and connectors, designed for fluid management, filtration, and bioreactor applications. The Allegro system is designed to reduce contamination risks and increase process flexibility and scalability.
• In 2019, Thermo Fisher Scientific launched its HyPerforma Single-Use Bioreactor, designed for high-density cell culture processes. The bioreactor incorporates a new film technology that allows for enhanced oxygen transfer, better mixing, and improved pH control. The system also features advanced sensors for real-time monitoring and control of the bioprocess.

Market Segmentation

Global Bioprocess Containers market is further segmented on the basis of type of containers, application, end user, and region. Based on the type of containers, the market can be segmented into 2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers, and Accessories. Based on application, the market can be further split into upstream process, downstream process, and process development. Based on end users, the market can be further divided into Biopharmaceutical Companies, Life Science R&D Companies, and Others. On the basis of region, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global bioprocess containers market on account of the established biopharmaceutical industry and the increasing adoption of single-use technologies in these regions.

Market Players

Thermo Fisher Scientific Inc., Cytiva Europe GmbH., Saint-Gobain Group., Lonza Group AG., Avantor Funding Inc., Merck KGaA., Sartorius AG., CellBios Healthcare and Lifesciences Pvt Ltd., Cole-Parmer Instrument Co., Biomass Ventures Pte Ltd. are some of the leading players operating in the Global Bioprocess Containers Market.

Report Scope:

In this report, global Bioprocess Containers market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Bioprocess Containers Market, By Type of Containers:

• 2D Bioprocess Containers
• 3D Bioprocess Containers
• Other Containers and Accessories

Bioprocess Containers Market, By Application:

• Upstream Process
• Downstream Process
• Process Development

Bioprocess Containers Market, By End User:

• Biopharmaceutical Companies
• Life Science R&D Companies
• Others

Bioprocess Containers Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bioprocess Containers Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bioprocess Containers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 5.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 5.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2022)
• 5.3. Market Map
  • 5.3.1 By Type of Containers
  • 5.3.2 By Application
  • 5.3.3 By End Users
  • 5.3.4 By Region

6. North America Bioprocess Containers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 6.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 6.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bioprocess Containers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Containers
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Bioprocess Containers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Containers
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Bioprocess Containers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Containers
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Bioprocess Containers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 7.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 7.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Bioprocess Containers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Containers
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Bioprocess Containers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Containers
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Bioprocess Containers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Containers
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Bioprocess Containers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Containers
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Bioprocess Containers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Containers
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Bioprocess Containers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 8.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 8.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Bioprocess Containers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Containers
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Bioprocess Containers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Containers
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Bioprocess Containers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Solution
      • 8.3.3.2.2. By Component
      • 8.3.3.2.3. By Development Model
      • 8.3.3.2.4. By Industry
  • 8.3.4. South Korea Bioprocess Containers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Containers
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Bioprocess Containers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Containers
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Bioprocess Containers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 9.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 9.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Bioprocess Containers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Containers
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Bioprocess Containers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Containers
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Bioprocess Containers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Containers
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Bioprocess Containers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 10.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 10.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Bioprocess Containers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Containers
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Bioprocess Containers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Containers
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Bioprocess Containers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Containers
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Bioprocess Containers Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 Thermo Fisher Scientific Inc.
  • 15.6.2 Cytiva Europe GmbH.
  • 15.6.3 Saint-Gobain Group.
  • 15.6.4 Lonza Group AG.
  • 15.6.5 Avantor Funding Inc.
  • 15.6.6 Merck KGaA.
  • 15.6.7 Sartorius AG.
  • 15.6.8 CellBios Healthcare and Lifesciences Pvt Ltd.
  • 15.6.9 Cole-Parmer Instrument Co.
  • 15.6.10 Biomass Ventures Pte Ltd.

16. Strategic Recommendations